68 related articles for article (PubMed ID: 26982182)
21. Dioscin inhibits non-small cell lung cancer cells and activates apoptosis by downregulation of Survivin.
Wang R; Li X; Gan Y; Liao J; Han S; Li W; Deng G
J Cancer; 2024; 15(5):1366-1377. PubMed ID: 38356707
[TBL] [Abstract][Full Text] [Related]
22. Combined inhibition of Stat3 and periostin synergistically protects mice against liver fibrosis.
Xiao H; Niu D; Zhang B
J Hepatol; 2024 May; 80(5):e207-e209. PubMed ID: 38081364
[No Abstract] [Full Text] [Related]
23. Correction to: Periostin secreted by cancer‑associated fibroblasts promotes cancer progression and drug resistance in non‑small cell lung cancer.
Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
J Mol Med (Berl); 2024 Jan; 102(1):147. PubMed ID: 38105305
[No Abstract] [Full Text] [Related]
24. Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway.
Zheng QM; Lu JJ; Zhao J; Wei X; Wang L; Liu PS
Biomed Res Int; 2016; 2016():9842619. PubMed ID: 27034956
[TBL] [Abstract][Full Text] [Related]
25. Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance.
Kazakova AN; Lukina MM; Anufrieva KS; Bekbaeva IV; Ivanova OM; Shnaider PV; Slonov A; Arapidi GP; Shender VO
Front Cell Dev Biol; 2024; 12():1403122. PubMed ID: 38818409
[No Abstract] [Full Text] [Related]
26. Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach.
Modabber N; Mahboub SS; Khoshravesh S; Karimpour F; Karimi A; Goodarzi V
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37804407
[TBL] [Abstract][Full Text] [Related]
27. The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression.
Li JM; Hsu PC; Kuan FC; Shi CS; Yang CT
Am J Cancer Res; 2022; 12(10):4637-4651. PubMed ID: 36381330
[TBL] [Abstract][Full Text] [Related]
28. Single-cell transcriptome analysis reveals T-cell exhaustion in denosumab-treated giant cell tumor of bone.
Yang M; Wang F; Lu G; Cheng M; Zhao W; Zou C
Front Immunol; 2022; 13():934078. PubMed ID: 36172351
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
Li M; Ma G; Li X; Zhou Q
Med Sci Monit; 2022 Jul; 28():e936898. PubMed ID: 35891604
[TBL] [Abstract][Full Text] [Related]
30. Expression of periostin according to endometrial cancer grade.
Herkiloglu D; Gokce S; Kaygusuz EI; Cevik O
Oncol Lett; 2022 Jul; 24(1):213. PubMed ID: 35707760
[TBL] [Abstract][Full Text] [Related]
31. Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.
Gül D; Schweitzer A; Khamis A; Knauer SK; Ding GB; Freudelsperger L; Karampinis I; Strieth S; Hagemann J; Stauber RH
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565465
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
33. Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma.
Massy E; Rousseau JC; Gueye M; Bonnelye E; Brevet M; Chambard L; Duruisseaux M; Borel O; Roger C; Guelminger R; Pialat JB; Gineyts E; Bouazza L; Millet M; Maury JM; Clézardin P; Girard N; Confavreux CB
J Bone Oncol; 2021 Aug; 29():100364. PubMed ID: 34150488
[TBL] [Abstract][Full Text] [Related]
34. Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer.
Li Z; Yang L; Wang H; Binzel DW; Williams TM; Guo P
Nucleic Acid Ther; 2021 Oct; 31(5):364-374. PubMed ID: 33999716
[TBL] [Abstract][Full Text] [Related]
35. Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.
Oo KK; Kamolhan T; Soni A; Thongchot S; Mitrpant C; O-Charoenrat P; Thuwajit C; Thuwajit P
BMC Cancer; 2021 Jan; 21(1):65. PubMed ID: 33446140
[TBL] [Abstract][Full Text] [Related]
36. Periostin Secreted by Carcinoma-Associated Fibroblasts Promotes Ovarian Cancer Cell Platinum Resistance Through the PI3K/Akt Signaling Pathway.
Chu L; Wang F; Zhang W; Li HF; Xu J; Tong XW
Technol Cancer Res Treat; 2020; 19():1533033820977535. PubMed ID: 33302812
[TBL] [Abstract][Full Text] [Related]
37. Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease.
Smirne C; Mulas V; Barbaglia MN; Mallela VR; Minisini R; Barizzone N; Burlone ME; Pirisi M; Grossini E
Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33255560
[TBL] [Abstract][Full Text] [Related]
38. STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy.
Yang PL; Liu LX; Li EM; Xu LY
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872659
[TBL] [Abstract][Full Text] [Related]
39. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
[TBL] [Abstract][Full Text] [Related]
40. Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.
Shibata M; Hoque MO
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
